ctrl K

AI Score

Unlock

Bellevue Life Sciences Ac... (BLAC)

AI Score

Unlock

3.01

-3.72 (-55.27%)

At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Cash & Equivalents	15.42K	124.5K	4.76K	62.65K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	36.61M	n/a	n/a	n/a
Other Long-Term Assets	n/a	1.1M	700.33K	260.1K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	7.21K	n/a	n/a	n/a
Total Current Assets	22.63K	124.5K	4.76K	62.65K
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	36.61M	1.1M	700.33K	260.1K
Total Assets	36.63M	1.23M	705.09K	322.75K
Account Payables	n/a	34K	2.85K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1.2M	400K	300K
Other Current Liabilities	1.51M	29.36K	304.36K	21.56K
Total Current Liabilities	2.04M	1.26M	707.21K	321.56K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.07M	n/a	n/a	n/a
Total Long-Term Liabilities	2.07M	1.23M	n/a	n/a
Total Liabilities	4.11M	1.26M	707.21K	321.56K
Total Debt	n/a	1.2M	400K	300K
Common Stock	36.43M	173.00	173.00	173.00
Retained Earnings	-3.91M	-62.51K	-27.12K	-23.81K
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	32.52M	-37.51K	-2.12K	1.19K
Total Investments	36.61M	n/a	n/a	n/a